请输入您要查询的百科知识:

 

词条 S100B
释义

  1. Function

  2. Clinical significance

  3. Diagnostic use

  4. Model organisms

  5. Interactions

  6. References

  7. Further reading

{{Infobox_gene}}

S100 calcium-binding protein B (S100B) is a protein of the S-100 protein family.

S100 proteins are localized in the cytoplasm and nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3.

Function

S100B is glial-specific and is expressed primarily by astrocytes, but not all astrocytes express S100B. It has been shown that S100B is only expressed by a subtype of mature astrocytes that ensheath blood vessels and by NG2-expressing cells.[1]

This protein may function in neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. In the developing CNS it acts as a neurotrophic factor and neuronal survival protein. In the adult organism it is usually elevated due to nervous system damage, which makes it a potential clinical marker.

Clinical significance

Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, schwannoma, melanoma, and type I diabetes.[2]

It has been suggested that the regulation of S100B by melittin has potential for the treatment of epilepsy.[3]

Diagnostic use

S100B is secreted by astrocytes or can spill from injured cells and enter the extracellular space or bloodstream. Serum levels of S100B increase in patients during the acute phase of brain damage. Over the last decade, S100B has emerged as a candidate peripheral biomarker of blood–brain barrier (BBB) permeability and CNS injury. Elevated S100B levels accurately reflect the presence of neuropathological conditions including traumatic head injury or neurodegenerative diseases. Normal S100B levels reliably exclude major CNS pathology. Its potential clinical use in the therapeutic decision making process is substantiated by a vast body of literature validating variations in serum 100B levels with standard modalities for prognosticating the extent of CNS damage: alterations in neuroimaging, cerebrospinal pressure, and other brain molecular markers (neuron specific enolase and glial fibrillary acidic protein). However, more importantly, S100B levels have been reported to rise prior to any detectable changes in intracerebral pressure, neuroimaging, and neurological examination findings. Thus, the major advantage of using S100B is that elevations in serum or CSF levels provide a sensitive measure for determining CNS injury at the molecular level before gross changes develop, enabling timely delivery of crucial medical intervention before irreversible damage occurs. S100B serum levels are elevated before seizures suggesting that BBB leakage may be an early event in seizure development.

[4]

An extremely important application of serum S100B testing is in the selection of patients with minor head injury who do not need further neuroradiological evaluation, as studies comparing CT scans and S100B levels have demonstrated S100B values below 0.12 ng/mL are associated with low risk of obvious neuroradiological changes (such as intracranial hemorrhage or brain swelling) or significant clinical sequelae.[5] The excellent negative predictive value of S100B in several neurological conditions is due to the fact that serum S100B levels reflect blood–brain barrier permeability changes even in absence of neuronal injury.[6][7]

In addition, S100B, which is also present in human melanocytes, is a reliable marker for melanoma malignancy both in bioptic tissue and in serum.[8][9]

Model organisms

Model organisms have been used in the study of S100B function. A conditional knockout mouse line, called S100btm1a(EUCOMM)Wtsi[14][15] was generated as part of the International Knockout Mouse Consortium program — a high-throughput mutagenesis project to generate and distribute animal models of disease to interested scientists — at the Wellcome Trust Sanger Institute.[16][17][18]

Male and female animals underwent a standardized phenotypic screen to determine the effects of deletion.[12][19] Twenty three tests were carried out on mutant mice, but no significant abnormalities have yet been observed.[12]

Interactions

S100B has been shown to interact with:

  • AHNAK,[20]
  • IMPA1,[21]
  • IQGAP1,[22]
  • MAPT,[23][24] and
  • P53,[25]
  • PGM1,[26]
  • S100A1,[27][28]
  • S100A6,[28][32]
  • S100A11,[29]
  • VAV1.[30]

References

1. ^{{cite journal | vauthors = Wang DD, Bordey A | title = The astrocyte odyssey | journal = Prog. Neurobiol. | volume = 86 | issue = 4 | pages = 342–67 | date = December 2008 | pmid = 18948166 | pmc = 2613184 | doi = 10.1016/j.pneurobio.2008.09.015 }}
2. ^{{cite web | title = Entrez Gene: S100B S100 calcium binding protein B| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6285| accessdate = }}
3. ^{{cite journal | vauthors = Verma N, Karmakar M, Singh KP, Smita S |date=February 2013 | title = Structural and Dynamic Insights into S100B Protein Activity Inhibition by Melittin for the Treatment of Epilepsy | journal = International Journal of Computer Applications | volume = NSAAILS | issue = 975 – 8887 | pages = 55–60 | url = http://www.ijcaonline.org/proceedings/nsaails/number1/10386-1012 }}
4. ^{{cite journal | vauthors = Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, Hallene K, Diglaw T, Franic L, Najm I, Janigro D | title = Seizure-promoting effect of blood–brain barrier disruption | journal = Epilepsia | volume = 48 | issue = 4 | pages = 732–42 | date = April 2007 | pmid = 17319915 | doi = 10.1111/j.1528-1167.2007.00988.x | pmc = 4135474 }}
5. ^{{cite journal | vauthors = Zongo D, Ribéreau-Gayon R, Masson F, Laborey M, Contrand B, Salmi LR, Montaudon D, Beaudeux JL, Meurin A, Dousset V, Loiseau H, Lagarde E | title = S100-B protein as a screening tool for the early assessment of minor head injury | journal = Annals of Emergency Medicine | volume = 59 | issue = 1 | pages = 209–218 | year = 2012 | pmid = 21944878 | doi = 10.1016/j.annemergmed.2011.07.027 }}
6. ^{{cite journal | vauthors = Czeisler BM, Janigro D | title = Reading and writing the blood–brain barrier: relevance to therapeutics | journal = Recent Patents on CNS Drug Discovery | volume = 1 | issue = 2 | pages = 157–73 | date = June 2006 | pmid = 18221201 | doi = 10.2174/157488906777452712 }}
7. ^{{cite journal | vauthors = Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, Janigro D | title = Peripheral markers of blood–brain barrier damage | journal = Clinica Chimica Acta | volume = 342 | issue = 1–2 | pages = 1–12 | date = April 2004 | pmid = 15026262 | doi = 10.1016/j.cccn.2003.12.008 }}
8. ^{{cite journal | vauthors = Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero L, Gazzolo D | title = The S100B protein in biological fluids: more than a lifelong biomarker of brain distress | journal = J. Neurochem. | volume = 120 | issue = 5 | pages = 644–59 | date = March 2012 | pmid = 22145907 | doi = 10.1111/j.1471-4159.2011.07612.x }}
9. ^{{cite journal | vauthors = Cocchia D, Michetti F, Donato R | title = Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin | journal = Nature | volume = 294 | issue = 5836 | pages = 85–7 | date = November 1981 | pmid = 7290214 | doi = 10.1038/294085a0 | bibcode = 1981Natur.294...85C }}
10. ^{{cite web |url=http://www.sanger.ac.uk/mouseportal/phenotyping/MCFR/salmonella-challenge/ |title=Salmonella infection data for S100b |publisher=Wellcome Trust Sanger Institute}}
11. ^{{cite web |url=http://www.sanger.ac.uk/mouseportal/phenotyping/MCFR/citrobacter-challenge/ |title=Citrobacter infection data for S100b |publisher=Wellcome Trust Sanger Institute}}
12. ^{{cite journal| doi = 10.1111/j.1755-3768.2010.4142.x| title = The Sanger Mouse Genetics Programme: High throughput characterisation of knockout mice| year = 2010| author = Gerdin AK| journal = Acta Ophthalmologica| volume = 88| issue = S248 | pages = 0}}
13. ^Mouse Resources Portal, Wellcome Trust Sanger Institute.
14. ^{{cite web |url=http://www.knockoutmouse.org/martsearch/search?query=S100b |title=International Knockout Mouse Consortium}}
15. ^{{cite web |url=http://www.informatics.jax.org/searchtool/Search.do?query=MGI:4432844 |title=Mouse Genome Informatics}}
16. ^{{cite journal | vauthors = Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, Mujica AO, Thomas M, Harrow J, Cox T, Jackson D, Severin J, Biggs P, Fu J, Nefedov M, de Jong PJ, Stewart AF, Bradley A | title = A conditional knockout resource for the genome-wide study of mouse gene function | journal = Nature | volume = 474 | issue = 7351 | pages = 337–42 | date = June 2011 | pmid = 21677750 | pmc = 3572410 | doi = 10.1038/nature10163 }}
17. ^{{cite journal | vauthors = Dolgin E | title = Mouse library set to be knockout | journal = Nature | volume = 474 | issue = 7351 | pages = 262–3 | date = June 2011 | pmid = 21677718 | doi = 10.1038/474262a }}
18. ^{{cite journal | vauthors = Collins FS, Rossant J, Wurst W | title = A mouse for all reasons | journal = Cell | volume = 128 | issue = 1 | pages = 9–13 | date = January 2007 | pmid = 17218247 | doi = 10.1016/j.cell.2006.12.018 }}
19. ^{{cite journal | vauthors = van der Weyden L, White JK, Adams DJ, Logan DW | title = The mouse genetics toolkit: revealing function and mechanism | journal = Genome Biol | volume = 12 | issue = 6 | pages = 224 | year = 2011 | pmid = 21722353 | pmc = 3218837 | doi = 10.1186/gb-2011-12-6-224 }}
20. ^{{cite journal | vauthors = Gentil BJ, Delphin C, Mbele GO, Deloulme JC, Ferro M, Garin J, Baudier J | title = The giant protein AHNAK is a specific target for the calcium- and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B | journal = J. Biol. Chem. | volume = 276 | issue = 26 | pages = 23253–61 | date = June 2001 | pmid = 11312263 | doi = 10.1074/jbc.M010655200 }}
21. ^{{cite journal | vauthors = Vig PJ, Shao Q, Subramony SH, Lopez ME, Safaya E | title = Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice | journal = Cerebellum | volume = 8 | issue = 3 | pages = 231–44 | date = September 2009 | pmid = 19593677 | pmc = 3351107 | doi = 10.1007/s12311-009-0125-5 }}
22. ^{{cite journal | vauthors = Mbele GO, Deloulme JC, Gentil BJ, Delphin C, Ferro M, Garin J, Takahashi M, Baudier J | title = The zinc- and calcium-binding S100B interacts and co-localizes with IQGAP1 during dynamic rearrangement of cell membranes | journal = J. Biol. Chem. | volume = 277 | issue = 51 | pages = 49998–50007 | date = December 2002 | pmid = 12377780 | doi = 10.1074/jbc.M205363200 }}
23. ^{{cite journal | vauthors = Yu WH, Fraser PE | title = S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease | journal = J. Neurosci. | volume = 21 | issue = 7 | pages = 2240–6 | date = April 2001 | pmid = 11264299 | doi = }}
24. ^{{cite journal | vauthors = Baudier J, Cole RD | title = Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II | journal = J. Biol. Chem. | volume = 263 | issue = 12 | pages = 5876–83 | date = April 1988 | pmid = 2833519 | doi = }}
25. ^{{cite journal | vauthors = Lin J, Yang Q, Yan Z, Markowitz J, Wilder PT, Carrier F, Weber DJ | title = Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells | journal = J. Biol. Chem. | volume = 279 | issue = 32 | pages = 34071–7 | date = August 2004 | pmid = 15178678 | doi = 10.1074/jbc.M405419200 }}
26. ^{{cite journal | vauthors = Landar A, Caddell G, Chessher J, Zimmer DB | title = Identification of an S100A1/S100B target protein: phosphoglucomutase | journal = Cell Calcium | volume = 20 | issue = 3 | pages = 279–85 | date = September 1996 | pmid = 8894274 | doi = 10.1016/S0143-4160(96)90033-0 }}
27. ^{{cite journal | vauthors = Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M | title = Towards a proteome-scale map of the human protein-protein interaction network | journal = Nature | volume = 437 | issue = 7062 | pages = 1173–8 | date = October 2005 | pmid = 16189514 | doi = 10.1038/nature04209 | bibcode = 2005Natur.437.1173R }}
28. ^{{cite journal | vauthors = Yang Q, O'Hanlon D, Heizmann CW, Marks A | title = Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma | journal = Exp. Cell Res. | volume = 246 | issue = 2 | pages = 501–9 | date = February 1999 | pmid = 9925766 | doi = 10.1006/excr.1998.4314 }}
29. ^{{cite journal | vauthors = Deloulme JC, Assard N, Mbele GO, Mangin C, Kuwano R, Baudier J | title = S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo | journal = J. Biol. Chem. | volume = 275 | issue = 45 | pages = 35302–10 | date = November 2000 | pmid = 10913138 | doi = 10.1074/jbc.M003943200 }}
30. ^{{cite journal | vauthors = Fackler OT, Luo W, Geyer M, Alberts AS, Peterlin BM | title = Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions | journal = Mol. Cell | volume = 3 | issue = 6 | pages = 729–39 | date = June 1999 | pmid = 10394361 | doi = 10.1016/S1097-2765(01)80005-8 }}

Further reading

{{refbegin | 2}}
  • {{cite journal | vauthors = Schäfer BW, Heizmann CW | title = The S100 family of EF-hand calcium-binding proteins: functions and pathology | journal = Trends Biochem. Sci. | volume = 21 | issue = 4 | pages = 134–40 | year = 1996 | pmid = 8701470 | doi = 10.1016/S0968-0004(96)80167-8 }}
  • {{cite journal | vauthors = Garbuglia M, Verzini M, Sorci G, Bianchi R, Giambanco I, Agneletti AL, Donato R | title = The calcium-modulated proteins, S100A1 and S100B, as potential regulators of the dynamics of type III intermediate filaments | journal = Braz. J. Med. Biol. Res. | volume = 32 | issue = 10 | pages = 1177–85 | year = 2000 | pmid = 10510252 | doi = 10.1590/s0100-879x1999001000001 }}
  • {{cite journal | vauthors = Rothermundt M, Peters M, Prehn JH, Arolt V | title = S100B in brain damage and neurodegeneration | journal = Microsc. Res. Tech. | volume = 60 | issue = 6 | pages = 614–32 | year = 2003 | pmid = 12645009 | doi = 10.1002/jemt.10303 }}
  • {{cite journal | vauthors = Michetti F, Gazzolo D | title = S100B testing in pregnancy | journal = Clin. Chim. Acta | volume = 335 | issue = 1–2 | pages = 1–7 | year = 2004 | pmid = 12927678 | doi = 10.1016/S0009-8981(03)00243-2 }}
  • {{cite journal | vauthors = Raabe A, Kopetsch O, Woszczyk A, Lang J, Gerlach R, Zimmermann M, Seifert V | title = Serum S-100B protein as a molecular marker in severe traumatic brain injury | journal = Restor. Neurol. Neurosci. | volume = 21 | issue = 3–4 | pages = 159–69 | year = 2004 | pmid = 14530578 | doi = }}
  • {{cite journal | vauthors = Sen J, Belli A | title = S100B in neuropathologic states: the CRP of the brain? | journal = J. Neurosci. Res. | volume = 85 | issue = 7 | pages = 1373–80 | year = 2007 | pmid = 17348038 | doi = 10.1002/jnr.21211 }}
  • {{cite journal | vauthors = Morii K, Tanaka R, Takahashi Y, Minoshima S, Fukuyama R, Shimizu N, Kuwano R | title = Structure and chromosome assignment of human S100 alpha and beta subunit genes | journal = Biochem. Biophys. Res. Commun. | volume = 175 | issue = 1 | pages = 185–91 | year = 1991 | pmid = 1998503 | doi = 10.1016/S0006-291X(05)81218-5 }}
  • {{cite journal | vauthors = Allore RJ, Friend WC, O'Hanlon D, Neilson KM, Baumal R, Dunn RJ, Marks A | title = Cloning and expression of the human S100 beta gene | journal = J. Biol. Chem. | volume = 265 | issue = 26 | pages = 15537–43 | year = 1990 | pmid = 2394738 | doi = }}
  • {{cite journal | vauthors = Duncan AM, Higgins J, Dunn RJ, Allore R, Marks A | title = Refined sublocalization of the human gene encoding the beta subunit of the S100 protein (S100B) and confirmation of a subtle t(9;21) translocation using in situ hybridization | journal = Cytogenet. Cell Genet. | volume = 50 | issue = 4 | pages = 234–5 | year = 1989 | pmid = 2530061 | doi = 10.1159/000132767 }}
  • {{cite journal | vauthors = Baudier J, Cole RD | title = Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II | journal = J. Biol. Chem. | volume = 263 | issue = 12 | pages = 5876–83 | year = 1988 | pmid = 2833519 | doi = }}
  • {{cite journal | vauthors = Allore R, O'Hanlon D, Price R, Neilson K, Willard HF, Cox DR, Marks A, Dunn RJ | title = Gene encoding the beta subunit of S100 protein is on chromosome 21: implications for Down syndrome | journal = Science | volume = 239 | issue = 4845 | pages = 1311–3 | year = 1988 | pmid = 2964086 | doi = 10.1126/science.2964086 | bibcode = 1988Sci...239.1311A }}
  • {{cite journal | vauthors = Jensen R, Marshak DR, Anderson C, Lukas TJ, Watterson DM | title = Characterization of human brain S100 protein fraction: amino acid sequence of S100 beta | journal = J. Neurochem. | volume = 45 | issue = 3 | pages = 700–5 | year = 1985 | pmid = 4031854 | doi = 10.1111/j.1471-4159.1985.tb04048.x }}
  • {{cite journal | vauthors = Baudier J, Glasser N, Haglid K, Gerard D | title = Purification, characterization and ion binding properties of human brain S100b protein | journal = Biochim. Biophys. Acta | volume = 790 | issue = 2 | pages = 164–73 | year = 1984 | pmid = 6487634 | doi = 10.1016/0167-4838(84)90220-6 }}
  • {{cite journal | vauthors = Adams MD, Kerlavage AR, Fleischmann RD, Fuldner RA, Bult CJ, Lee NH, Kirkness EF, Weinstock KG, Gocayne JD, White O | title = Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence | journal = Nature | volume = 377 | issue = 6547 Suppl | pages = 3–174 | year = 1995 | pmid = 7566098 | doi = | url = http://www.columbia.edu/itc/biology/pollack/w4065/client_edit/readings/nature377_3.pdf | format = PDF }}
  • {{cite journal | vauthors = Schäfer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW | title = Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family | journal = Genomics | volume = 25 | issue = 3 | pages = 638–43 | year = 1995 | pmid = 7759097 | doi = 10.1016/0888-7543(95)80005-7 }}
  • {{cite journal | vauthors = Reeves RH, Yao J, Crowley MR, Buck S, Zhang X, Yarowsky P, Gearhart JD, Hilt DC | title = Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 91 | issue = 12 | pages = 5359–63 | year = 1994 | pmid = 8202493 | pmc = 43994 | doi = 10.1073/pnas.91.12.5359 | bibcode = 1994PNAS...91.5359R }}
  • {{cite journal | vauthors = Engelkamp D, Schäfer BW, Mattei MG, Erne P, Heizmann CW | title = Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 90 | issue = 14 | pages = 6547–51 | year = 1993 | pmid = 8341667 | pmc = 46969 | doi = 10.1073/pnas.90.14.6547 | bibcode = 1993PNAS...90.6547E }}
  • {{cite journal | vauthors = Peña LA, Brecher CW, Marshak DR | title = beta-Amyloid regulates gene expression of glial trophic substance S100 beta in C6 glioma and primary astrocyte cultures | journal = Brain Res. Mol. Brain Res. | volume = 34 | issue = 1 | pages = 118–26 | year = 1997 | pmid = 8750867 | doi = 10.1016/0169-328X(95)00145-I }}
  • {{cite journal | vauthors = Argandoña EG, Bengoetxea H, Lafuente JV | title = Physical exercise is required for environmental enrichment to offset the quantitative effects of dark-rearing on the S-100β astrocytic density in the rat visual cortex | journal = Journal of Anatomy | volume = 215 | issue = 2 | pages = 132–40 | year = 2009 | pmid = 19500177 | pmc = 2740960 | doi = 10.1111/j.1469-7580.2009.01103.x }}
  • {{cite journal | vauthors = Landar A, Caddell G, Chessher J, Zimmer DB | title = Identification of an S100A1/S100B target protein: phosphoglucomutase | journal = Cell Calcium | volume = 20 | issue = 3 | pages = 279–85 | year = 1997 | pmid = 8894274 | doi = 10.1016/S0143-4160(96)90033-0 }}
{{refend}}{{PDB Gallery|geneid=6285}}{{NLM content}}{{DEFAULTSORT:S100b}}

3 : Molecular neuroscience|S100 proteins|Genes mutated in mice

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/22 7:33:19